UK
UK
Jul-17
Jul-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreJul-17
Cardiovascular Pharmacoepidemiology
Read moreApr-17
Cardiovascular Pharmacoepidemiology
Read moreApr-17
Cardiovascular Pharmacoepidemiology Rheumatology
Read moreMar-17
Cardiovascular Virology and Immunisations
Read moreMar-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreMar-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreMar-17
Cardiovascular Pharmacoepidemiology
Read moreFeb-17
Cardiovascular Pharmacoepidemiology
Read moreJan-17
| Date | Title | Categories | |
|---|---|---|---|
| Jul-17 | Relationship between initial therapy and blood pressure control for high-risk hypertension patients in the UK: a retrospective cohort study from the THIN general practice database | Read more | |
| Jul-17 | The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study | Read more | |
| Jul-17 | Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors) | Read more | |
| Apr-17 | Use of azithromycin and risk of ventricular arrhythmia | Read more | |
| Apr-17 | Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Aspirin: A Case-crossover Study and a Propensity Score-matched Cohort Study | Read more | |
| Apr-17 | Survival following a diagnosis of heart failure in primary care | Read more | |
| Mar-17 | A meta-analysis of stroke risk following herpes zoster infection | Read more | |
| Mar-17 | Adding a Glucagon like peptide‐1 analogue (GLP‐1RA) has a favourable effect on mortality and cardiovascular events among insulin‐treated patients with Type 2 diabetes: a large retrospective UK cohort study | Read more | |
| Mar-17 | Obesity as a predictor of five year cardiovascular (CV) outcomes and mortality in patients with Type 2 diabetes started on insulin therapy: real world evidence in UK primary care | Read more | |
| Mar-17 | Lower Rates of Hospitalization for Heart Failure and All-Cause Death in New Users of SGLT-2 Inhibitors Versus Other Glucose Lowering Drugs – Real World Data from Six Countries and More Than 300,000 Patients: the CVD-REAL Study | Read more | |
| Feb-17 | Relative risks of cardiovascular disease in people prescribed olanzapine, risperidone and quetiapine | Read more | |
| Jan-17 | Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011 | Read more |
